ADDEX THERAPEUTICS LTD (ADXN) Stock Income Statement
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 592.40K | 1.65M | 1.45M | 3.15M | 3.88M | |||
| Operating Expenses | 5.58M | 11.93M | 21.97M | 18.66M | 16.12M | |||
| Research and Development | 2.28M | 6.94M | 14.64M | 12.82M | 10.36M | |||
| Selling, General, and Administrative Expenses | 3.13M | 4.96M | 7.29M | 5.81M | 5.74M | |||
| Operating Income | -4.99M | -10.28M | -20.52M | -15.51M | -12.24M | |||
| Interest Income/Expense | -1.58M | -274.90K | -284.00K | 308.00K | -615.30K | |||
| Other Income/Expense | N/A | N/A | N/A | -220.00K | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -6.58M | -10.56M | -20.80M | -15.20M | -12.86M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Net Income | 5.40M | -10.56M | -20.80M | -15.20M | -12.86M | |||
| EBITDA | -4.68M | -9.98M | -20.20M | -15.16M | -11.86M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 4.73 | -13.07 | -42.34 | -40.96 | -44.32 | |||
| Non GAAP EPS | N/A | N/A | -9.54 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | 912.34% | -640.90% | -1439.74% | -481.97% | -331.48% | |||
| Operating Profit Margin | -842.67% | -624.21% | -1420.08% | -491.74% | -315.62% | |||
All data in CHF